» Articles » PMID: 35832788

Rnd3 Expression is Necessary to Maintain Mitochondrial Homeostasis but Dispensable for Autophagy

Abstract

Autophagy is a highly conserved process that mediates the targeting and degradation of intracellular components to lysosomes, contributing to the maintenance of cellular homeostasis and to obtaining energy, which ensures viability under stress conditions. Therefore, autophagy defects are common to different neurodegenerative disorders. Rnd3 belongs to the family of Rho GTPases, involved in the regulation of actin cytoskeleton dynamics and important in the modulation of cellular processes such as migration and proliferation. Murine models have shown that Rnd3 is relevant for the correct development and function of the Central Nervous System and lack of its expression produces several motor alterations and neural development impairment. However, little is known about the molecular events through which Rnd3 produces these phenotypes. Interestingly we have observed that Rnd3 deficiency correlates with the appearance of autophagy impairment profiles and irregular mitochondria. In this work, we have explored the impact of Rnd3 loss of expression in mitochondrial function and autophagy, using a Rnd3 KO CRISPR cell model. Rnd3 deficient cells show no alterations in autophagy and mitochondria turnover is not impaired. However, Rnd3 KO cells have an altered mitochondria oxidative metabolism, resembling the effect caused by oxidative stress. In fact, lack of Rnd3 expression makes these cells strictly dependent on glycolysis to obtain energy. Altogether, our results demonstrate that Rnd3 is relevant to maintain mitochondria function, suggesting a possible relationship with neurodegenerative diseases.

Citing Articles

Rnd3 protects against doxorubicin-induced cardiotoxicity through inhibition of PANoptosis in a Rock1/Drp1/mitochondrial fission-dependent manner.

Ge W, Zhang X, Lin J, Wang Y, Zhang X, Duan Y Cell Death Dis. 2025; 16(1):2.

PMID: 39755713 PMC: 11700182. DOI: 10.1038/s41419-024-07322-0.


Exosomal MicroRNAs: Biomarkers of moyamoya disease and involvement in vascular cytoskeleton reconstruction.

Wang M, Zhang B, Jin F, Li G, Cui C, Feng S Heliyon. 2024; 10(11):e32022.

PMID: 38868045 PMC: 11168404. DOI: 10.1016/j.heliyon.2024.e32022.


RND3 Potentiates Proinflammatory Activation through NOTCH Signaling in Activated Macrophages.

de Avila M, Lopez-Lopez S, Garcia-Blazquez A, Ruiz-Garcia A, Gonzalez-Gomez M, Nueda M J Immunol Res. 2024; 2024:2264799.

PMID: 38343633 PMC: 10857877. DOI: 10.1155/2024/2264799.


The gene expression landscape of the human locus coeruleus revealed by single-nucleus and spatially-resolved transcriptomics.

Weber L, Divecha H, Tran M, Kwon S, Spangler A, Montgomery K Elife. 2024; 12.

PMID: 38266073 PMC: 10945708. DOI: 10.7554/eLife.84628.

References
1.
Ballester-Lurbe B, Poch E, Mocholi E, Guasch R, Perez-Roger I, Terrado J . RhoE is spatiotemporally regulated in the postnatal mouse CNS. Neuroscience. 2009; 163(2):586-93. DOI: 10.1016/j.neuroscience.2009.06.062. View

2.
Negishi M, Katoh H . Rho family GTPases as key regulators for neuronal network formation. J Biochem. 2002; 132(2):157-66. DOI: 10.1093/oxfordjournals.jbchem.a003205. View

3.
Xu S, Zhang X, Liu C, Liu Q, Chai H, Luo Y . Role of Mitochondria in Neurodegenerative Diseases: From an Epigenetic Perspective. Front Cell Dev Biol. 2021; 9:688789. PMC: 8429841. DOI: 10.3389/fcell.2021.688789. View

4.
Panchal K, Tiwari A . Miro (Mitochondrial Rho GTPase), a key player of mitochondrial axonal transport and mitochondrial dynamics in neurodegenerative diseases. Mitochondrion. 2020; 56:118-135. DOI: 10.1016/j.mito.2020.10.005. View

5.
Wang P, Niidome T, Akaike A, Kihara T, Sugimoto H . Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene. J Neurosci Res. 2009; 87(9):2105-14. DOI: 10.1002/jnr.22039. View